NLRP3 and major depressive disorder: The tryptophan metabolite quinolinic acid mediated by it activates the NLRP3 inflammatory body of microglia, causing microglia to abnormally devour synaptic components, damage synaptic plasticity, and promote the development of MDD (Li S. et al., 2022).